Cargando…
Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal
Clinicians in molecular tumor boards (MTB) are confronted with a growing amount of genetic high-throughput sequencing data. Today, at German university hospitals, these data are usually handled in complex spreadsheets from which clinicians have to obtain the necessary information. The aim of this wo...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167859/ https://www.ncbi.nlm.nih.gov/pubmed/32050609 http://dx.doi.org/10.3390/diagnostics10020093 |
_version_ | 1783523604074332160 |
---|---|
author | Buechner, Philipp Hinderer, Marc Unberath, Philipp Metzger, Patrick Boeker, Martin Acker, Till Haller, Florian Mack, Elisabeth Nowak, Daniel Paret, Claudia Schanze, Denny von Bubnoff, Nikolas Wagner, Sebastian Busch, Hauke Boerries, Melanie Christoph, Jan |
author_facet | Buechner, Philipp Hinderer, Marc Unberath, Philipp Metzger, Patrick Boeker, Martin Acker, Till Haller, Florian Mack, Elisabeth Nowak, Daniel Paret, Claudia Schanze, Denny von Bubnoff, Nikolas Wagner, Sebastian Busch, Hauke Boerries, Melanie Christoph, Jan |
author_sort | Buechner, Philipp |
collection | PubMed |
description | Clinicians in molecular tumor boards (MTB) are confronted with a growing amount of genetic high-throughput sequencing data. Today, at German university hospitals, these data are usually handled in complex spreadsheets from which clinicians have to obtain the necessary information. The aim of this work was to gather a comprehensive list of requirements to be met by cBioPortal to support processes in MTBs according to clinical needs. Therefore, oncology experts at nine German university hospitals were surveyed in two rounds of interviews. To generate an interview guideline a scoping review was conducted. For visual support in the second round, screenshot mockups illustrating the requirements from the first round were created. Requirements that cBioPortal already meets were skipped during the second round. In the end, 24 requirements with sometimes several conceivable options were identified and 54 screenshot mockups were created. Some of the identified requirements have already been suggested to the community by other users or are currently being implemented in cBioPortal. This shows, that the results are in line with the needs expressed by various disciplines. According to our findings, cBioPortal has the potential to significantly improve the processes and analyses of an MTB after the implementation of the identified requirements. |
format | Online Article Text |
id | pubmed-7167859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71678592020-04-21 Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal Buechner, Philipp Hinderer, Marc Unberath, Philipp Metzger, Patrick Boeker, Martin Acker, Till Haller, Florian Mack, Elisabeth Nowak, Daniel Paret, Claudia Schanze, Denny von Bubnoff, Nikolas Wagner, Sebastian Busch, Hauke Boerries, Melanie Christoph, Jan Diagnostics (Basel) Article Clinicians in molecular tumor boards (MTB) are confronted with a growing amount of genetic high-throughput sequencing data. Today, at German university hospitals, these data are usually handled in complex spreadsheets from which clinicians have to obtain the necessary information. The aim of this work was to gather a comprehensive list of requirements to be met by cBioPortal to support processes in MTBs according to clinical needs. Therefore, oncology experts at nine German university hospitals were surveyed in two rounds of interviews. To generate an interview guideline a scoping review was conducted. For visual support in the second round, screenshot mockups illustrating the requirements from the first round were created. Requirements that cBioPortal already meets were skipped during the second round. In the end, 24 requirements with sometimes several conceivable options were identified and 54 screenshot mockups were created. Some of the identified requirements have already been suggested to the community by other users or are currently being implemented in cBioPortal. This shows, that the results are in line with the needs expressed by various disciplines. According to our findings, cBioPortal has the potential to significantly improve the processes and analyses of an MTB after the implementation of the identified requirements. MDPI 2020-02-10 /pmc/articles/PMC7167859/ /pubmed/32050609 http://dx.doi.org/10.3390/diagnostics10020093 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Buechner, Philipp Hinderer, Marc Unberath, Philipp Metzger, Patrick Boeker, Martin Acker, Till Haller, Florian Mack, Elisabeth Nowak, Daniel Paret, Claudia Schanze, Denny von Bubnoff, Nikolas Wagner, Sebastian Busch, Hauke Boerries, Melanie Christoph, Jan Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal |
title | Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal |
title_full | Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal |
title_fullStr | Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal |
title_full_unstemmed | Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal |
title_short | Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal |
title_sort | requirements analysis and specification for a molecular tumor board platform based on cbioportal |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167859/ https://www.ncbi.nlm.nih.gov/pubmed/32050609 http://dx.doi.org/10.3390/diagnostics10020093 |
work_keys_str_mv | AT buechnerphilipp requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT hinderermarc requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT unberathphilipp requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT metzgerpatrick requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT boekermartin requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT ackertill requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT hallerflorian requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT mackelisabeth requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT nowakdaniel requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT paretclaudia requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT schanzedenny requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT vonbubnoffnikolas requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT wagnersebastian requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT buschhauke requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT boerriesmelanie requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal AT christophjan requirementsanalysisandspecificationforamoleculartumorboardplatformbasedoncbioportal |